Rigel Pharmaceuticals, Inc. (RIGL): Price and Financial Metrics

RIGL POWR Grades

• Value is the dimension where RIGL ranks best; there it ranks ahead of 94.84% of US stocks.
• RIGL's strongest trending metric is Momentum; it's been moving down over the last 52 weeks.
• RIGL ranks lowest in Momentum; there it ranks in the 9th percentile.

RIGL Stock Summary

• The price/operating cash flow metric for Rigel Pharmaceuticals Inc is higher than 99.84% of stocks in our set with a positive cash flow.
• For RIGL, its debt to operating expenses ratio is greater than that reported by merely 20.96% of US equities we're observing.
• Revenue growth over the past 12 months for Rigel Pharmaceuticals Inc comes in at 33.4%, a number that bests 79.56% of the US stocks we're tracking.
• Stocks that are quantitatively similar to RIGL, based on their financial statements, market capitalization, and price volatility, are ALLT, GEOS, CYRN, MRIN, and SMSI.
• RIGL's SEC filings can be seen here. And to visit Rigel Pharmaceuticals Inc's official web site, go to www.rigel.com.

RIGL Valuation Summary

• In comparison to the median Healthcare stock, RIGL's price/sales ratio is 60.35% lower, now standing at 4.5.
• RIGL's price/sales ratio has moved down 11.1 over the prior 243 months.
• RIGL's EV/EBIT ratio has moved down 148 over the prior 243 months.

Below are key valuation metrics over time for RIGL.

RIGL Growth Metrics

• Its 5 year price growth rate is now at -13.66%.
• The 3 year cash and equivalents growth rate now stands at 423.48%.
• Its 4 year price growth rate is now at -28.47%.

Over the past 67 months, RIGL's revenue has gone up $115,228,000.

The table below shows RIGL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	144.123	0.207	-7.732
2021-03-31	133.878	-69.047	-11.487
2020-12-31	108.621	-52.185	-29.744
2020-09-30	105.571	-46.262	-27.707
2020-06-30	108.039	-41.421	-25.023
2020-03-31	102.425	-44.034	-28.053

RIGL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RIGL has a Quality Grade of B, ranking ahead of 89.82% of graded US stocks.
• RIGL's asset turnover comes in at 0.886 -- ranking 27th of 680 Pharmaceutical Products stocks.
• SBBP, CSBR, and NSTG are the stocks whose asset turnover ratios are most correlated with RIGL.

The table below shows RIGL's key quality metrics over time.